| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10909099 | Leukemia Research | 2013 | 7 Pages |
Abstract
The cell line provides a suitable material for cellular and molecular studies of tumor abnormalities, with potentially unique mutagenic features of myeloma disease. It may be utilized for human hybridoma construction and vaccine development. Both IL-6 dependent and independent cell clones represent an important model for studies of myeloma cell growth and resistance emerging during targeted therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lenka Uherková, Irena VanÄurová, Ilona VyhlÃdalová, Markéta Pleschnerová, Ivan Å piÄka, Romana Mihalová, Jana BÅezinová, ZdenÄk Hodný, Kamila Äermáková, Veronika Polanská, Iuri Marinov, Petr L. Jedelský, KateÅina Kuželová,